ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells

Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-associated antigens for T cell activation thanks to the release of damage-associated molecular patterns, including ATP. Here, we tested the hypothesis that in acute myeloid leukemia (AML), ATP release, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecciso, Mariangela, Ocadlikova, Darina, Sangaletti, Sabina, Trabanelli, Sara, De Marchi, Elena, Orioli, Elisa, Pegoraro, Anna, Portararo, Paola, Jandus, Camilla, Bontadini, Andrea, Redavid, Annarita, Salvestrini, Valentina, Romero, Pedro, Colombo, Mario P., Di Virgilio, Francesco, Cavo, Michele, Adinolfi, Elena, Curti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744438/
https://www.ncbi.nlm.nih.gov/pubmed/29312358
http://dx.doi.org/10.3389/fimmu.2017.01918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744438/
https://www.ncbi.nlm.nih.gov/pubmed/29312358
http://dx.doi.org/10.3389/fimmu.2017.01918

Ejemplares similares